Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 57 for “"RAS mutations"”.

  1. Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies (detection of RAS mutations with digital PCR)

    … cancer and is associated with high mortality. RAS status is an important biomarker, as it guides treatment by predicting response to anti-EGFR monoclonal antibodies. However, RAS is routinely tested only on archival tumour tissue, and it is not possible to update the information on its status …

    greece Repository record for Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies (detection of RAS mutations with digital PCR) (opens in a new tab)

  2. PHARMACOLOGIC RESTORATION OF GTP HYDROLYSIS SENSITIZES CELLS TO SHP2 INHIBITION IN RAS-MUTANT FUSION-NEGATIVE RHABDOMYOSARCOMA

    … (FN-RMS), is often driven by hyperactive RAS signaling. Direct RAS inhibitors have yet to be evaluated in pediatric malignancies. Alternative targets to inhibit hyperactive RAS signaling include SHP2. SHP2 promotes RAS-SOS1 interaction, leading to GDP/GTP exchange and RAS activation. …

    jhu Repository record for PHARMACOLOGIC RESTORATION OF GTP HYDROLYSIS SENSITIZES CELLS TO SHP2 INHIBITION IN RAS-MUTANT FUSION-NEGATIVE RHABDOMYOSARCOMA (opens in a new tab)

  3. Impact of Kras/Nras Mutational Heterogeneity On Clinical Outcomes In Colorectal Cancer

    Introduction: Mutations in KRAS/NRAS (RAS) predict a lack of benefit from anti-EGFR agents in metastatic colorectal cancer (mCRC). As next generation sequencing (NGS) has advanced, we are discovering atypical and low allele frequency mutations. We aimed to evaluate how NGS can optimally define RAS …

    uthsc Repository record for Impact of Kras/Nras Mutational Heterogeneity On Clinical Outcomes In Colorectal Cancer (opens in a new tab)

  4. Μελέτη του ογκογονιδίου RAS και της μεταλλαγμένης μορφής του ογκοκατασταλτικού ογκογονιδίου P53 σε πλακώδη καρκινώματα πνεύμονα

    … DNA repair and initiation of apoptosis. P53 mutations are detected in more than 50% of human tumours. Ras oncogene is also important for carcinogenesis, as its GTPase functioning protein product is critical for signal transduction. Ras mutations are frequently detected in human tumours …

    greece Repository record for Μελέτη του ογκογονιδίου RAS και της μεταλλαγμένης μορφής του ογκοκατασταλτικού ογκογονιδίου P53 σε πλακώδη καρκινώματα πνεύμονα (opens in a new tab)

  5. Elucidating the Mechanisms Underlying the Mutational Bias of RAS Genes in Cancer Using a Chemical Carcinogenesis Mouse Model

    <p>Missense oncogenic mutations in the RAS genes are found in around 20% of all human cancers, which are known to be tumorigenic. Despite scores of different oncogenic RAS mutations detected in human cancers, these mutations have distinct patterns, often with a specific set of mutations unique to …

    duke Repository record for Elucidating the Mechanisms Underlying the Mutational Bias of RAS Genes in Cancer Using a Chemical Carcinogenesis Mouse Model (opens in a new tab)

  6. blmp-1 is a Ras-cooperating Tumor Suppressor Gene in Caenorhabditis elegans

    While hypermorphic Ras mutations are found in approximately 35% of colorectal, 45% of lung and 90% of pancreatic cancers, activated Ras alone is not sufficient to transform normal cells into cancerous tumors. Additional driver mutations or epigenetic alterations are required to cooperate with the …

    toronto-retro Repository record for blmp-1 is a Ras-cooperating Tumor Suppressor Gene in Caenorhabditis elegans (opens in a new tab)

  7. Prognostic molecular markers in resected ductal pancreatic carcinoma

    … DNA obtained from microdissected specimens. Mutations in codons 12 and 13 of the K-ras oncogene were detected by SSCP and sequencing following DNA extraction and amplification by PCR. The median [range] survival post-resection was 12.5 [3-83] months. Abnormalities of p16\(^{INK4}\), p53, …

    birmingham Download PDF for Prognostic molecular markers in resected ductal pancreatic carcinoma (opens in a new tab)

  8. Gene mutations in experimental models of carcinogenesis and their effects on responses to chemopreventive agents in the azoxymethane-treated rat model

    The Ki-ras oncogene and the p53 tumor suppressor gene are mutated in a high percentage of human colon cancers. The mutation status of these two genes were assessed in colon adenocarcinomas obtained from azoxymethane (AOM)- and dimethylhydrazine (DMH)-treated rats, widely used experimental models of …

    arizona-thes Repository record for Gene mutations in experimental models of carcinogenesis and their effects on responses to chemopreventive agents in the azoxymethane-treated rat model (opens in a new tab)

  9. Interaction of beta-adrenergic receptors, NNK, and ethanol in selected pancreatic carcinoma cell lines

    … Tobacco and alcohol are risk factors. Ki-ras and p53 commonly occur in genetic mutations, 75&percnt; and 50&percnt; respectively. However, the interconnection between these risk factors and genetic mutations and their role in pancreatic carcinogenesis has not been consistent. It has been …

    utk-theses Repository record for Interaction of beta-adrenergic receptors, NNK, and ethanol in selected pancreatic carcinoma cell lines (opens in a new tab)

  10. Genomic Characterization of Response and Resistance to Immunotherapy in Black Patients with Non-Small Cell Lung Cancer

    … sequencing (NGS) data encompassing 607,863 mutations in 66,372 tumors across 51 cancer types obtained from the AACR Project GENIE Registry to better understand the genomic landscape of cancers harboring RAS mutations stratified by racial background. These analyses revealed a differential …

    jhu Repository record for Genomic Characterization of Response and Resistance to Immunotherapy in Black Patients with Non-Small Cell Lung Cancer (opens in a new tab)

  11. Genetic Aberrations Associated With Metastasis in Colorectal Cancer: An Insight Into Tumour Heterogeneity

    … (i), determination of frequency and nature of mutations in KA-ras and (ii), determination of the nature and extent of genetic aberrations, at chromosomal level, in advanced colorectal cancer. The main theme of the work was the use of paired tumour samples from the same patients in an attempt to …

    glasgow Download PDF for Genetic Aberrations Associated With Metastasis in Colorectal Cancer: An Insight Into Tumour Heterogeneity (opens in a new tab)

  12. Inhibition of RAS as a novel therapeutic approach in Luminal B breast cancer.

    Historically, the RAS oncoprotein has not been implicated in breast cancer due to less than 1% of breast cancer cases bearing oncogenic RAS mutations. Recently, however, it has been reported that greater than 60% of Luminal B breast cancer cases have a decreased expression of negative RAS …

    louisville Repository record for Inhibition of RAS as a novel therapeutic approach in Luminal B breast cancer. (opens in a new tab)

  13. ELUCIDATING THE FUNCTION OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE (ICMT) IN CANCER

    Isoprenylcysteine carboxylmethyltransferase (Icmt), the enzyme catalyzing the last step of the prenylation pathway for proteins with C-terminal CaaX-motifs such as Ras, has been investigated for its potential to be developed as a target for cancer therapy, especially for mutant Ras-driven cancers. …

    nus Repository record for ELUCIDATING THE FUNCTION OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE (ICMT) IN CANCER (opens in a new tab) Download file for ELUCIDATING THE FUNCTION OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE (ICMT) IN CANCER (opens in a new tab)

  14. Αλληλεπίδραση των ογκογονιδίων ras με παπίλλομα-ιούς και ερπητο-ιούς σε γυναικολογικές νεοπλασίες

    … alterations. In the present study activation of ras genes was examined in female genital lesions. Breast carcinomas were also included due to the higher prevalence of such tumors in women. Presence of the human papillomavirus (HPV) as well as the herpesviruses CMV, HSV and EBV was also detected …

    greece Repository record for Αλληλεπίδραση των ογκογονιδίων ras με παπίλλομα-ιούς και ερπητο-ιούς σε γυναικολογικές νεοπλασίες (opens in a new tab)

  15. ΔΟΜΙΚΗ ΚΑΙ ΛΕΙΤΟΥΡΓΙΚΗ ΑΝΑΛΥΣΗ ΤΗΣ ΟΙΚΟΓΕΝΕΙΑΣ ΤΩΝ ΟΓΚΟΓΟΝΙΔΙΩΝ RAS

    … STRUCTURAL AND FUNCTIONAL MODIFICATIONS OF THE RAS GENES. QUANTITATIVE, COMPETITIVE (RT-)PRC - RFLP ASSAYS WERE DEVELOPED TO DETECT AND DISCRIMINATE THE EXPRESSION OF MUTANT VERSUS WILD - TYPE ALLELES OF THE K - RAS AND H - RAS GENE. ANALYSIS OF COLORECTAL TUMORS ESTABLISHED CODON 12 AND CODON …

    greece Repository record for ΔΟΜΙΚΗ ΚΑΙ ΛΕΙΤΟΥΡΓΙΚΗ ΑΝΑΛΥΣΗ ΤΗΣ ΟΙΚΟΓΕΝΕΙΑΣ ΤΩΝ ΟΓΚΟΓΟΝΙΔΙΩΝ RAS (opens in a new tab)

  16. Expressão da iodotironina desiodase tipo 3 no carcinoma diferenciado de tireóide

    … on differentiated thyroid tumorigenesis. Point mutations in BRAF and RAS genes and RET/PTC rearrangements are observed in about 70% of PTC cases. Follicular carcinomas commonly harbor RAS mutations and PAX8-PPARJ rearrangements. Anaplastic carcinomas may harbor a wide set of genetic alterations, …

    brazil-ufrgs Repository record for Expressão da iodotironina desiodase tipo 3 no carcinoma diferenciado de tireóide (opens in a new tab)

  17. The role of FBXO11 in human hematopoiesis

    … sequencing study has revealed frequent somatic mutations in ubiquitin proteasome system (UPS) genes, with recurrent loss-of-function mutations in FBXO11, which codes substrate-recognition component for E3 ubiquitin ligase complex. Our mouse transplant model shows a biological cooperation between …

    ubc Repository record for The role of FBXO11 in human hematopoiesis (opens in a new tab) Download PDF for The role of FBXO11 in human hematopoiesis (opens in a new tab)

  18. Regulation of expression of the intestinal MUC2 gene in vitro and in vivo

    … differences, such as frequency of p53 and Ki-ras mutations suggested that development of mucinous and nonmucinous tumours occurs along two distinct genetic pathways. To clarify the details of these pathways, the mechanism of MUC2 gene expression regulation was investigated. In the present work …

    fu-berlin Repository record for Regulation of expression of the intestinal MUC2 gene in vitro and in vivo (opens in a new tab)

Page 1 of 3